LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer 2026

View at publisher
Authors: Jabra G. Zarka, Ronit Juthani, Oliver Sartor, Miguel Muniz, Adam McLain Kase, Irbaz B Riaz, Arsalan Naqvi, Elisabeth Heath, Jacob J. Orme, Zachary Scharf, Gokce Belge Bilgin, Eugene D. Kwon
+10 more Albert Jang, Ali Tarhini, Geoffrey B. Johnson, MD Ayse Tuba Kendi, Matthew P. Thorpe, Mrinal S. Patnaik, Yael N. Kusne, Heather Jacene, Praful Ravi, Daniel S. Childs
DOI: 10.1016/j.clgc.2026.102552
Cited by: 1
References: 19

Fields of Study & Subjects

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
Clinical Genitourinary Cancer
Publisher
Elsevier BV
Volume
24
Issue
4
Pages
102552–102552
Publication date
28 March 2026
Language
EN